Inventor
ALESSI THOMAS R
US29 patents
⚠️ This page may combine multiple inventors who share the name “ALESSI THOMAS R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INTARCIA THERAPEUTICS INC
14 patentsUS7879028B2Feb 1, 2011
Osmotic delivery systems and piston assemblies for use therein
INTARCIA THERAPEUTICS INC72 citations97
US7682356B2Mar 23, 2010
Osmotic delivery systems and piston assemblies for use therein
INTARCIA THERAPEUTICS INC84 citations97
US9682127B2Jun 20, 2017
Osmotic delivery device comprising an insulinotropic peptide and uses thereof
INTARCIA THERAPEUTICS INC21 citations94
US9572889B2Feb 21, 2017
Devices, formulations, and methods for delivery of multiple beneficial agents
INTARCIA THERAPEUTICS INC23 citations93
US9889085B1Feb 13, 2018
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
INTARCIA THERAPEUTICS INC18 citations91
US8343140B2Jan 1, 2013
Devices, formulations, and methods for delivery of multiple beneficial agents
INTARCIA THERAPEUTICS INC30 citations91
US11246913B2Feb 15, 2022
Suspension formulation comprising an insulinotropic peptide
INTARCIA THERAPEUTICS INC0 citations62
US12042557B2Jul 23, 2024
Rapid establishment and/or termination of substantial steady-state drug delivery
INTARCIA THERAPEUTICS INC0 citations58
US10527170B2Jan 7, 2020
Osmotic delivery systems and piston assemblies for use therein
INTARCIA THERAPEUTICS INC0 citations52
US10363287B2Jul 30, 2019
Method of manufacturing an osmotic delivery device
INTARCIA THERAPEUTICS INC0 citations52
US10441528B2Oct 15, 2019
Devices, formulations, and methods for delivery of multiple beneficial agents
INTARCIA THERAPEUTICS INC0 citations50
US10583080B2Mar 10, 2020
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
INTARCIA THERAPEUTICS INC0 citations49
US10869830B2Dec 22, 2020
Rapid establishment and/or termination of substantial steady-state drug delivery
INTARCIA THERAPEUTICS INC0 citations48
US10231923B2Mar 19, 2019
Rapid establishment and/or termination of substantial steady-state drug delivery
INTARCIA THERAPEUTICS INC0 citations48
AMERICAN HOME PROD
9 patentsUS4897405AJan 30, 1990
Novel naphthalenylalkyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents
AMERICAN HOME PROD62 citations96
US4895862AJan 23, 1990
Novel benzyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents
AMERICAN HOME PROD47 citations92
US4966975AOct 30, 1990
Processes for the preparation of novel naphthalenylmethyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents
AMERICAN HOME PROD2 citations63
US4895860AJan 23, 1990
Novel substituted 3H-1,2,3,5-oxathiadiazole 2-oxides useful as anthihyperglycemic agents
AMERICAN HOME PROD3 citations63
US4786638ANov 22, 1988
2,4-disubstituted-5-cyano-1,6-dihydro-6-oxo-1-pyrimidineacetic acid aldose reductase inhibitors
AMERICAN HOME PROD4 citations63
US4786640ANov 22, 1988
2,6-disubstituted-5-cyano-4-pyrimidinyloxyacetic acid aldose reductase inhibitors
AMERICAN HOME PROD2 citations63
US4906753AMar 6, 1990
Preparation of 2,6-disubstituted-5-cyano-4-pyrimidinyloxyacetic acid aldose reductase inhibitors
AMERICAN HOME PROD1 citations52
US4900829AFeb 13, 1990
2,4-disubstituted-5-cyano-1,6-dihydro-6-oxo-1-pyrimidineacetic acid aldose reductase inhibitors
AMERICAN HOME PROD1 citations52
US4895861AJan 23, 1990
Novel naphthalenyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents
AMERICAN HOME PROD1 citations52
ALESSI THOMAS R
5 patentsUS8801700B2Aug 12, 2014
Osmotic delivery systems and piston assemblies for use therein
ALESSI THOMAS R46 citations97
US8299025B2Oct 30, 2012
Suspension formulations of insulinotropic peptides and uses thereof
ALESSI THOMAS R55 citations97
US8940316B2Jan 27, 2015
Osmotic delivery comprising an insulinotropic peptide and uses thereof
ALESSI THOMAS R29 citations93
US8926595B2Jan 6, 2015
Devices, formulations, and methods for delivery of multiple beneficial agents
ALESSI THOMAS R31 citations92
US8298561B2Oct 30, 2012
Rapid establishment and/or termination of substantial steady-state drug delivery
ALESSI THOMAS R30 citations91